[
    {
        "source": "原文 : 1.重要不良反应",
        "hyp": "文 4 : 1. Important adverse reactions",
        "label_text": "adverse reactions"
    },
    {
        "source": "原文 : （4）中毒性表皮坏死松解症（Toxic Epidermal Necrolysis：TEN）、皮肤黏膜眼综合征（Stevens-Johnson综合征）",
        "hyp": "文 1 : Toxic epidermal necrosis (TEN) and Stevens-Johnson syndrome (SIDS) are the most common causes of blindness.",
        "label_text": "epidermal necrosis"
    },
    {
        "source": "原文 : 严重的肾功能衰竭（eGFR<45mL/min/1.73m2）；",
        "hyp": "文 3 : severe kidney failure (eGFR is less than 45 mL/min/1.73 m2);",
        "label_text": "severe"
    },
    {
        "source": "原文 : 进一步对该方法的灵敏度、特异性与线性范围等分析性能进行验证，结果显示同一反应体系中katG315的响应范围为1.0 pmol/L至0.1 nmol/L，rpoB531和rpsL43的响应范围为1.0 pmol/L至50.0 pmol/L和1.0 pmol/L至20.0 pmol/L，且该方法具有较好的特异度与灵敏度，在混合靶标中可精确识别单碱基突变，最低检出限低至1.0 pmol/L；在模拟血清样本的回收实验中，回收率可达95.0%~105.2%。",
        "hyp": "文 2 : Further verification of the analytical performance of the method, such as sensitivity, specificity and linearity, showed that the response range of katG315 in the same reaction system was 1.0 ppmolL to 0.1 nmolL, the response range of rpoB531 and rpsL was 1.0 pmolL to 50.0 pmolL and 1.0 pmolL to 0.0 pmolL, and the method had better specificity and sensitivity, with accuracy in identifying single base mutations, with a minimum output of 1.0 pmolL.",
        "label_text": "ppmolL"
    },
    {
        "source": "原文 : 因为再等待 20 分钟就已经等了 1 个小时 #NUMBER# 分鐘了",
        "hyp": "文 1 : If you wait another 20 minutes, you've already waited an hour. #NUMBER #Minute",
        "label_text": "M"
    },
    {
        "source": "原文 : “很多疾病早期检测、切除不到位，跟医生手术室用的灯有关 。 ”",
        "hyp": "文 4 : <unk> Early detection of many diseases <unk> Failure to remove the site is related to the lights used in the doctor's operating room <unk> <unk>",
        "label_text": "F"
    },
    {
        "source": "原文 : 应用LogistiC回归分析影响二三线疗效的因素. 三组患者治疗3、6、12个月达完全血液学反应（CHR）、主要细胞遗传学反应（MCyR）、主要分子学反应（MMR）率比较差异均有统计学意义（P<0.05）。",
        "hyp": "文 2 : Application of LogistiC regression analysis to factors affecting secondary and tertiary efficacy. Three groups of patients treated for 3-6-12 months achieved complete hematological response (CHR) <unk> major cell genetic response (MCyR) <unk> major molecular response (MMR) rate comparison differences were statistically significant (P<0.05) <unk>",
        "label_text": "LogistiC"
    }
]